Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

WuXi NextCODE

WuXi NextCODE
2015 FOUNDED
PRIVATE STATUS
301-400 EMPLOYEES
Series C LATEST DEAL TYPE
$200M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of a global genomics platform designed to provide genomic sequence data. The company's platform offers study design, sequencing, storage and interpretation, as well as offers secondary analysis and scalable analytics, enabling organizations around the world to improve patient health using the human genome.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Biotechnology
Primary Office
  • 55 Cambridge Parkway
  • 8th Floor
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore WuXi NextCODE’s full profile, request a free trial.

WuXi NextCODE Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 27-Nov-2018 $200M 00000 Completed Generating Revenue
3. Secondary Transaction - Private 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 07-Sep-2017 $240M $240M Completed Generating Revenue
1. Early Stage VC (Series A) Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

WuXi NextCODE Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InterpretOmics Corporate Backed or Acquired Bangalore, India 00.000 000000000 00.000
000000 Venture Capital-Backed Palo Alto, CA 0 0000 0000000000 0 0000
000000 00000000 Venture Capital-Backed Oakland, CA 00 000.00 00000000000 000.00
000000 00000000 Venture Capital-Backed Saint Sulpice, Switzerland 000 00000 00000000000 00000
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

WuXi NextCODE Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 06-Feb-2019 00000 00000 00 0000 Other Healthcare Technology Systems
00000000 00000000 27-Nov-2018 000000000000000000 Biotechnology 000 0000000
00000 (00000000000 21-May-2018 00000 00000 00 00000 Biotechnology
Claritas Genomics 26-Jan-2015 Early Stage VC 0000 Laboratory Services (Healthcare) 000000 00รก00000
To view this company’s complete investment and acquisition history, request access »

WuXi NextCODE Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 00000000 26-Jan-2015 00000 00000 00 0000 Completed
  • 4 buyers
To view this company’s complete exits history, request access »

WuXi NextCODE Subsidiaries (1)

Company Name Industry Location Founded
00000000 00000000 Biotechnology Dublin, Ireland 0000
To view this company’s complete subsidiary history, request access »

WuXi NextCODE Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Ireland Strategic Investment Fund Sovereign Wealth Fund Minority 000 0000 000000 0
3W Partners Capital PE/Buyout Minority 000 0000 000000 0
Ally Bridge Group PE/Buyout Minority 000 0000 000000 0
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

WuXi NextCODE Executive Team (14)

Name Title Board
Seat
Contact
Info
Rob Brainin Chief Executive Officer
John Long Chief Financial Officer
Alex Fowkes Chief Strategy Officer
Hongye Sun Ph.D Chief Technology Officer
Hakon Gudbjartsson Ph.D Chief Informatics Officer

3 Former Executives

You’re viewing 5 of 14 executives. Get the full list »

WuXi NextCODE Board Members (1)

Name Representing Role Since Contact
Info
Ge Li Ph.D Self Chairman 000 0000